ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

4DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Apg-1387, 1570231-89-8, E53vn70k2x, Apg1387, (s,5s,5's,8s,8's,10ar,10a'r)-3,3'-(1,3-phenylenedisulfonyl)bis(n-benzhydryl-5-((s)-2-(methylamino)propanamido)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide), Unii-e53vn70k2x

Molecular Formula

C₆₀H₇₂N₁₀O₁₀S₂

Molecular Weight

1157.4 g/mol

InChI Key

AKLBERUGKZNEJY-RTEPGWBGSA-N

FDA UNII

E53VN70K2X

IAP Inhibitor APG-1387 is a small molecule, second mitochondria-derived activator of caspases (SMAC)-mimetic targeting inhibitor of apoptosis proteins (IAPs) with potential apoptosis-inducing and antineoplastic activities. Upon administration, IAP inhibitor APG-1387 selectively binds to and inhibits the activity of IAPs including X chromosome-linked IAP (XIAP) and cellular IAPs 1 (c-IAP1) and 2 (c-IAP2). This may restore and promote the induction of apoptosis through apoptotic signaling pathways and enhance proteasomal degradation of IAPs. Additionally, APG-1387 may work synergistically with cytotoxic drugs to overcome tumor cell resistance to apoptosis. IAPs are overexpressed by many cancer cell types, suppressing apoptosis by binding and inhibiting active caspases-3, -7 and -9 via their BIR (baculoviral lAP repeat) domains.

1 2D Structure

APG-1387

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(5S,8S,10aR)-3-[3-[[(5S,8S,10aR)-8-(benzhydrylcarbamoyl)-5-[[(2S)-2-(methylamino)propanoyl]amino]-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocin-3-yl]sulfonyl]phenyl]sulfonyl-N-benzhydryl-5-[[(2S)-2-(methylamino)propanoyl]amino]-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide

2.1.2 InChI

InChI=1S/C60H72N10O10S2/c1-39(61-3)55(71)63-49-37-67(34-32-45-28-30-51(69(45)59(49)75)57(73)65-53(41-18-9-5-10-19-41)42-20-11-6-12-21-42)81(77,78)47-26-17-27-48(36-47)82(79,80)68-35-33-46-29-31-52(70(46)60(76)50(38-68)64-56(72)40(2)62-4)58(74)66-54(43-22-13-7-14-23-43)44-24-15-8-16-25-44/h5-27,36,39-40,45-46,49-54,61-62H,28-35,37-38H2,1-4H3,(H,63,71)(H,64,72)(H,65,73)(H,66,74)/t39-,40-,45+,46+,49-,50-,51-,52-/m0/s1

2.1.3 InChI Key

AKLBERUGKZNEJY-RTEPGWBGSA-N

2.1.4 Canonical SMILES

CC(C(=O)NC1CN(CCC2CCC(N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)S(=O)(=O)C5=CC(=CC=C5)S(=O)(=O)N6CCC7CCC(N7C(=O)C(C6)NC(=O)C(C)NC)C(=O)NC(C8=CC=CC=C8)C9=CC=CC=C9)NC

2.1.5 Isomeric SMILES

C[C@@H](C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(C3=CC=CC=C3)C4=CC=CC=C4)S(=O)(=O)C5=CC(=CC=C5)S(=O)(=O)N6CC[C@H]7CC[C@H](N7C(=O)[C@H](C6)NC(=O)[C@H](C)NC)C(=O)NC(C8=CC=CC=C8)C9=CC=CC=C9)NC

2.2 Other Identifiers

2.2.1 UNII

E53VN70K2X

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Apg-1387

2.3.2 Depositor-Supplied Synonyms

1. Apg-1387

2. 1570231-89-8

3. E53vn70k2x

4. Apg1387

5. (s,5s,5's,8s,8's,10ar,10a'r)-3,3'-(1,3-phenylenedisulfonyl)bis(n-benzhydryl-5-((s)-2-(methylamino)propanamido)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide)

6. Unii-e53vn70k2x

7. Schembl15490706

8. Apg-1387 [who-dd]

9. A][1,5]diazocine-8-carboxamide)

10. Ex-a5180

11. Apg-1387 (smac Mimetic)

12. Nsc834197

13. Nsc-834197

14. Sm-1387

15. Hy-125593

16. Cs-0092417

17. Phenylenedisulfonyl)bis(n-benzhydryl-5-((s)-2-

18. (methylamino)propanamido)-6-oxodecahydropyrrolo[1,2-

19. (5s,5's,8s,8's,10ar,10a'r)-3,3'-(1,3-

2.4 Create Date

2014-03-31

3 Chemical and Physical Properties

Molecular Formula	C₆₀H₇₂N₁₀O₁₀S₂
Molecular Weight	1157.4 g/mol
XLogP3	4.5
Hydrogen Bond Donor Count	6
Hydrogen Bond Acceptor Count	14
Rotatable Bond Count	18
Exact Mass	1156.48743088 g/mol
Monoisotopic Mass	1156.48743088 g/mol
Topological Polar Surface Area	273 Å²
Heavy Atom Count	82
Formal Charge	0
Complexity	2240
Isotope Atom Count	0
Defined Atom Stereocenter Count	8
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1